Stool-Based Screening Tests for Colorectal Cancer

被引:5
|
作者
Carethers, John M. M. [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA USA
[2] Univ Calif San Diego, Dept Med, Div Gastroenterol, Biomed Sci Bldg,Room 1318A,9500 Gilman Dr, La Jolla, CA 92093 USA
来源
关键词
D O I
10.1001/jama.2023.0547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 56-year-old man with no significant medical history has declined screening colonoscopy at previous physician visits but wants to undergo a less invasive test because his father died of colorectal cancer at age 80. What would you do next?
引用
收藏
页码:839 / 840
页数:2
相关论文
共 50 条
  • [21] Colonoscopy and stool-based DNA testing preferred for routine colorectal cancer screening (CRCS)
    Lal, S
    Zamor, P
    Glick, J
    Heeren, T
    Schroy, PC
    GASTROENTEROLOGY, 2004, 126 (04) : A346 - A346
  • [22] New stool screening tests for colorectal cancer
    Young, Graeme P.
    Cole, Stephen
    DIGESTION, 2007, 76 (01) : 26 - 33
  • [23] UNSATISFACTORY STOOL TESTS IN COLORECTAL CANCER SCREENING
    Liu, Po-Hong
    Nair, Rasmi
    Murphy, Caitlin C.
    Kim, Eric
    Ortiz, Cynthia
    Wang, Lei
    Skinner, Celette S.
    Halm, Ethan
    GASTROENTEROLOGY, 2022, 162 (07) : S699 - S699
  • [24] Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening
    van Wifferen, Francine
    Greuter, Marjolein J. E.
    Lissenberg-Witte, Birgit, I
    Carvalho, Beatriz
    Meijer, Gerrit A.
    Dekker, Evelien
    Campari, Cinzia
    Garcia, Montse
    Rabeneck, Linda
    Lansdorp-Vogelaar, Iris
    Senore, Carlo
    Coupe, Veerle M. H.
    PREVENTIVE MEDICINE, 2022, 164
  • [25] Critical Adherence to Blood-Based vs Stool-Based Screening for Colorectal Cancer: A Scenario Analysis
    Meester, Reinier
    Piscitello, Andrew
    Baldo, Lance
    Liang, Peter S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S254 - S255
  • [26] Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
    Kisiel, John B.
    Fendrick, A. Mark
    Ebner, Derek W.
    Ozbay, A. Burak
    Vahdat, Vahab
    Estes, Chris
    Limburg, Paul J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 746 - 753
  • [27] Assessing the effects of pharmacist education on colorectal cancer screening and access to a stool-based DNA test
    Moore, Madysen S.
    Ruisinger, Janelle F.
    Johnson, Lesley M.
    Melton, Brittany L.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : S14 - S19
  • [28] Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
    Karlitz, Jordan J.
    Fendrick, A. Mark
    Bhatt, Jay
    Coronado, Gloria D.
    Jeyakumar, Sushanth
    Smith, Nathaniel J.
    Plescia, Marcus
    Brooks, Durado
    Limburg, Paul
    Lieberman, David
    POPULATION HEALTH MANAGEMENT, 2022, 25 (03) : 343 - 351
  • [29] Changes in uptake of stool-based colorectal cancer screening during the Covid-19 pandemic
    Eric A. Miller
    Paul F. Pinsky
    Cancer Causes & Control, 2023, 34 : 887 - 895
  • [30] Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing
    Roth, Joshua A.
    deVos, Theo
    Ramsey, Scott D.
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (05): : 256 - 262